Xencor, Inc. (XNCR): Price and Financial Metrics
Xencor, Inc. (XNCR)
Today's Latest Price: $39.17 USD
Updated Oct 26 9:31am
Add XNCR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
XNCR Stock Summary
- With a price/sales ratio of 31.55, Xencor Inc has a higher such ratio than 94.34% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Xencor Inc is reporting a growth rate of -261.97%; that's higher than only 7.12% of US stocks.
- Revenue growth over the past 12 months for Xencor Inc comes in at -58.87%, a number that bests just 3.14% of the US stocks we're tracking.
- Stocks that are quantitatively similar to XNCR, based on their financial statements, market capitalization, and price volatility, are NKTR, DNLI, ARVN, PRQR, and FATE.
- XNCR's SEC filings can be seen here. And to visit Xencor Inc's official web site, go to www.xencor.com.
XNCR Stock Price Chart Interactive Chart >
XNCR Price/Volume Stats
| Current price | $39.17 | 52-week high | $43.90 |
| Prev. close | $39.48 | 52-week low | $19.35 |
| Day low | $38.68 | Volume | 1,866 |
| Day high | $39.21 | Avg. volume | 410,408 |
| 50-day MA | $38.16 | Dividend yield | N/A |
| 200-day MA | $33.42 | Market Cap | 2.24B |
Xencor, Inc. (XNCR) Company Bio
Xencor Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases and cancer. The company was founded in 1997 and is based in Monrovia, California.
Loading social stream, please wait...